Sakara Seng, DO
Internal Medicine · Redondo Beach
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 9 years
- Graduated 2017
Offices
1 location · Torrance Health Association Inc · 298 clinicians in this group
Looking this up.
Hospitals listed: Torrance Memorial Medical Center · 555599. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Seng’s office at (310) 750-3300 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Torrance Memorial Medical CenterTorrance, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.36 (1.11 to 1.61), Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 15.79 (10.51 to 21.07) · 1,494 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.21 (0.72 to 1.71) · 9,154 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.328, Oct 2024 – Sep 2025
See every measure and the patient survey for Torrance Memorial Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.36 (1.11 to 1.61) | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.79 (10.51 to 21.07) · 1,494 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.21 (0.72 to 1.71) · 9,154 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.328 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.72) · 2,154 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.72 (128.91 to 214.54) · 121 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 36 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 176 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.8 · 766 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 806 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 608 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 7,587 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.1 to 0.47) · 11,109 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.03 to 0.39) · 11,330 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.13 (2.41 to 5.85) · 2,964 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0.13 to 3.16) · 1,513 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.66 (1.3 to 4.01) · 2,802 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.24 (2.35 to 8.14) · 1,479 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.55 (0.11 to 2.98) · 650 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2 · 962 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.023 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.646 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.259 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.658 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 1,578 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 21.1 · 183 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 1.5 · 900 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.9 · 800 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.1 · 1,223 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.3) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7 to 15) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 928 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21 · 316 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.5 to 16.1) · 624 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 781 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,607 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$61,004
Medicare paid this office $61,004 for 163 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 98 | $36,810 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $10,039 | $136 |
| Hospital discharge day management, more than 30 minutes | 94 | $9,216 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $4,016 | $65 |
Who their Medicare patients are
163 Original Medicare patients in 2024. Average age 77 · Under 65 10% · 85 and older 26% · Women 55% · Also on Medicaid 35% · Health risk score 2.79. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Chronic kidney disease 50% · Diabetes 44% · Coronary heart disease 42% · Heart failure 42% · Depression 42% · Atrial fibrillation 39% · Dementia 27% · COPD 26% · Cancer 24% · Stroke 13%.
The office billed $140,484, Medicare allowed $77,417 and paid $61,004; for 624 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 163 | 624 | 77 | 2.79 | $140,484 | $61,004 |
| 2023 | 297 | 1,003 | 78 | 2.58 | $219,251 | $94,578 |
| 2022 | 295 | 981 | 78 | 2.44 | $204,407 | $84,263 |
| 2021 | 307 | 837 | 76 | 2.70 | $515,312 | $79,886 |
| 2020 | 123 | 261 | 76 | 1.96 | $224,529 | $26,855 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 159 | $47,553 | $96 |
| Hospital discharge day management, more than 30 minutes | 182 | $18,002 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 117 | $16,863 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $10,432 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $1,075 | $36 |
2022: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 122 | $29,205 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 100 | $14,995 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 87 | $14,458 | $161 |
| Hospital discharge day management, more than 30 minutes | 134 | $12,680 | $89 |
| Initial hospital observation care per day, typically 70 minutes | 24 | $3,443 | $143 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,282 | $109 |
| Hospital observation care on day of discharge | 36 | $2,266 | $60 |
| Hospital discharge day management, 30 minutes or less | 13 | $801 | $62 |
2021: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 122 | $27,960 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 111 | $14,128 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $13,723 | $193 |
| Hospital discharge day management, more than 30 minutes | 103 | $11,602 | $107 |
| Initial hospital observation care per day, typically 70 minutes | 19 | $3,040 | $160 |
| Hospital observation care on day of discharge | 33 | $2,306 | $70 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 34 | $1,983 | $38 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,573 | $131 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,370 | $69 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $10,614 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $4,799 | $77 |
| Hospital discharge day management, more than 30 minutes | 42 | $4,655 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,453 | $216 |
| Hospital observation care on day of discharge | 12 | $954 | $80 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $541 | $42 |
Medicaid work
$5,264 in 2021
Medicaid paid $5,264 for 309 billed services this clinician did in 2021, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 84 | $1,918 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 105 | $1,449 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 103 | $1,448 |
| 1ST HOSP IP/OBS HIGH 75 | 17 | $449 |
| 2021 | 309 | 4 | 23 | $5,264 |
| 2020 | 225 | 3 | 27 | $5,952 |
See the largest Medicaid services in earlier years
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 117 | $3,124 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 59 | $1,553 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 49 | $1,275 |
Drugs they prescribed that Part D paid
$24,299
Pharmacies billed $24,299 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (14 of 282) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
225 generic and fewer than 11 brand-name prescriptions · $24,299 in drug cost · 46 antibiotic prescriptions to 38 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $6,497 | $591 |
| Jardiance | 11 | $6,417 | $583 |
| Amoxicillin-Clavulanate Potass | 14 | $83 | $6 |
| Prednisone | 15 | $31 | $2 |
| Furosemide | 11 | $23 | $2 |
See all 6 drugs
| Eliquis | 11 | $6,497 | $591 |
| Jardiance | 11 | $6,417 | $583 |
| Amoxicillin-Clavulanate Potass | 14 | $83 | $6 |
| Prednisone | 15 | $31 | $2 |
| Furosemide | 11 | $23 | $2 |
| Amlodipine Besylate | 12 | $18 | $1 |
Year by year
| 2024 | 282 | 110 | 5% (14) | None | $24,299 |
| 2023 | 339 | 156 | 10% (34) | None | $24,991 |
| 2022 | 317 | 165 | 8% (24) | None | $21,103 |
| 2021 | 251 | 112 | 6% (16) | None | $15,023 |
| 2020 | 102 | 39 | None | None | $6,402 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Eliquis | 16 | $9,576 | $599 |
| Ciprofloxacin | 19 | $200 | $11 |
| Amoxicillin-Clavulanate Potass | 12 | $74 | $6 |
| Furosemide | 18 | $70 | $4 |
| Prednisone | 12 | $57 | $5 |
| Tramadol | 14 | $26 | $2 |
2022: 6 drugs
| Eliquis | 13 | $7,197 | $554 |
| Ciprofloxacin | 14 | $131 | $9 |
| Amoxicillin-Clavulanate Potass | 15 | $92 | $6 |
| Prednisone | 16 | $63 | $4 |
| Furosemide | 19 | $59 | $3 |
| Sulfamethoxazole-Trimethoprim | 11 | $38 | $3 |
2021: 4 drugs
| Albuterol Sulfate Hfa | 11 | $442 | $40 |
| Atorvastatin | 14 | $107 | $8 |
| Amoxicillin-Clavulanate Potass | 11 | $85 | $8 |
| Furosemide | 15 | $68 | $5 |
2020: 1 drug
| Atorvastatin | 11 | $67 | $6 |
Money from drug and device companies
$254 in 2025
| 2025 | 4 | 10 | None | $254 |
| 2024 | 7 | 20 | None | $409 |
| 2023 | 11 | 50 | None | $1,134 |
| 2022 | 7 | 30 | None | $569 |
| 2021 | 3 | 3 | None | $57 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | None | $132 | 5 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $55 | 2 payments
|
| Verona Pharma | Ohtuvayre | $46 | 2 payments
|
| Cytovale | None | $21 | 1 payment
|
See all 10 published payments
| Cytovale | Meals · 2025-11-23 | None | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-08-28 | Lifevest | $31 |
| Abiomed | Meals · 2025-08-14 | None | $27 |
| Verona Pharma | Meals · 2025-07-17 | Ohtuvayre | $24 |
| Verona Pharma | Meals · 2025-06-25 | Ohtuvayre | $22 |
| Abiomed | Meals · 2025-06-12 | None | $19 |
| Abiomed | Meals · 2025-05-09 | None | $27 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-02 | Lifevest | $24 |
| Abiomed | Meals · 2025-04-17 | None | $33 |
| Abiomed | Meals · 2025-02-20 | None | $25 |
See earlier years (2024, 2023, 2022, 2021)
2024: $409
| Janssen Pharmaceuticals | Xarelto | $109 | 6 payments
|
| Abiomed | Impella | $95 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $65 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $44 | 2 payments
|
| Shionogi | Fetroja | $36 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $35 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $23 | 1 payment
|
2023: $1,134
| Abiomed | Impella | $316 | 11 payments
|
| Merck Sharp & Dohme | Dificid | $177 | 9 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $126 | 6 payments
|
| Novartis Pharmaceuticals | Entresto | $125 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $124 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $86 | 5 payments
|
| Shionogi | Fetroja | $69 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $46 | 2 payments
|
| bioMerieux | Nephrocheck Liquid Control Kit | $28 | 1 payment
|
| Aimmune Therapeutics | Vowst | $23 | 1 payment
|
| AbbVie | Teflaro | $15 | 1 payment
|
2022: $569
| Novartis Pharmaceuticals | Entresto | $208 | 10 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $103 | 6 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $100 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $68 | 4 payments
|
| Merck Sharp & Dohme | Dificid | $50 | 3 payments
|
| Pfizer | Eliquis | $23 | 1 payment
|
| Shionogi | Fetroja | $15 | 1 payment
|
2021: $57
| Janssen Pharmaceuticals | Xarelto | $21 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
| Pfizer | Eliquis | $17 | 1 payment
|
Professional record
- NPI
- 1114472446
- Licence
- CA 20A17326
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 906 Burbank Dr Apt 10, Santa Clara, CA, 95051
- NPI first listed
- 2016-08-16
- NPI last updated
- 2020-06-26
- NPI record certified
- 2020-06-26
This is when the NPI record was last certified, not a medical board exam.